Inhibition of Angiopoietin-2 Production by Myofibrocytes Inhibits Neointimal Hyperplasia After Endoluminal Injury in Mice

Frontiers in Immunology
D ChenA Dorling

Abstract

Fibrocytes are myeloid lineage cells implicated in wound healing, repair, and fibrosis. We previously showed that fibrocytes are mobilized into the circulation after vascular injury, including the immune-mediated injury that occurs after allogeneic transplantation. A common response to inflammatory vascular injury is intimal hyperplasia (IH), which, alongside vascular remodeling, results in progressive loss of blood flow, downstream ischemia, and end-organ fibrosis. This forms the pathological basis of transplant arteriosclerosis and other diseases including post-angioplasty re-stenosis. In investigating whether fibrocytes contribute to IH, we previously showed that subpopulations expressing smooth muscle actin and CD31 are recruited to the site of injury and accumulate in the neointima. Expression of tissue factor (TF) by these "CD31+ myofibrocytes" is needed for progressive neointimal expansion, such that TF inhibition limits the neointima to a single layer of cells by day 28 post-injury. The aim of this study was to determine pathophysiological mediators downstream of TF that contribute to myofibrocyte-orchestrated IH. We first show that myofibrocytes make up a significant component of the neointima 28 days following injury....Continue Reading

References

Mar 12, 2003·Circulation·Antti I NykänenKarl B Lemström
Apr 1, 2003·Proceedings of the National Academy of Sciences of the United States of America·Noel M CapliceWilliam D Edwards
Jan 17, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Cristina CalviMaria Felice Brizzi
May 5, 2005·Journal of Thrombosis and Haemostasis : JTH·D KirchhoferS Bunting
Sep 17, 2005·Circulation Research·Annika ArmulikChrister Betsholtz
May 13, 2006·Journal of Thrombosis and Haemostasis : JTH·R L VarcoeH J Medbury
Oct 19, 2006·Trends in Immunology·Ulrike Fiedler, Hellmut G Augustin
Jan 12, 2007·Journal of Leukocyte Biology·Alexandre BrkovicMartin G Sirois
May 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Craig MurdochClaire E Lewis
Jul 17, 2010·The British Journal of Dermatology·C A StatonN J Brown
Mar 19, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Raphael A NemenoffMary C M Weiser-Evans
Mar 10, 2015·Cytokine·Korina LymperopoulouStylianos E Orfanos
Mar 17, 2015·Annals of the New York Academy of Sciences·Alexander ScholzYvonne Reiss
Aug 13, 2015·Transplant International : Official Journal of the European Society for Organ Transplantation·Michael N ThomasJoachim Andrassy
Jun 1, 2016·Journal of Thrombosis and Haemostasis : JTH·K RathnakumarM Dixit

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
FCS
ELISA
transfection
Dissection
SMA

Software Mentioned

- TCS - NT
Pro Plus
Leica
GraphPad Prism
Image

Related Concepts

Related Feeds

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.